On August 31, 2023 BeiGene (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global biotechnology company, reported that the Company will participate in the Morgan Stanley 21st Annual Global Healthcare Conference on Monday, September 11th, 2023 with a fireside chat at 9:20 am ET (Press release, BeiGene, AUG 31, 2023, View Source [SID1234634796]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

A live webcast of this event can be accessed from the investors section of BeiGene’s website at View Source, View Source or View Source Archived replays will be available for 90 days following the event.

On August 31, 2023 Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to develop transformative therapies for patients with cancer and autoimmune diseases, reported that Pascal Touchon, President and Chief Executive Officer, will participate in a Cell Therapies in Autoimmune panel discussion at the Citi 18th Annual BioPharma Conference on Thursday, September 7, 2023 at 10:50 a.m. PDT / 1:50 p.m. EDT (Press release, Atara Biotherapeutics, AUG 31, 2023, View Source [SID1234634795]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

A live webcast of the presentation will be available by visiting the Investors and Media section of atarabio.com. An archived replay of the webcast will be available on the Company’s website for 30 days following the live presentation.

On August 31, 2023 Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, reported that management will participate in two investor conferences in September (Press release, Anixa Biosciences, AUG 31, 2023, View Source [SID1234634794]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

H.C. Wainwright 25th Annual Global Investment Conference: Anixa’s pre-recorded presentation will be available on demand during the event for all registered attendees. Beginning on Monday, September 11, 2023, the presentation will also be available on the Company’s website at Investor Relations/Events & Presentations.

2023 Cantor Global Healthcare Conference: Anixa management is scheduled to present on Thursday, September 28, 2023 at 8:00 AM ET in New York City. The presentation will be broadcast live and archived on the Company’s website at Investor Relations/Events & Presentations.

Management will be available for one-on-one meetings with interested investors at both conferences.

On August 31, 2023 Amgen (NASDAQ:AMGN) reported that it will present at the 2023 Wells Fargo Healthcare Conference at 9:30 a.m. ET on Wednesday, Sept. 6, 2023 (Press release, Amgen, AUG 31, 2023, View Source [SID1234634793]). Amgen will also present at the Citi Global Healthcare Conference at 1:00 p.m. ET on Thursday, Sept. 7, 2023. Peter H. Griffith, executive vice president and chief financial officer at Amgen, and Murdo Gordon, executive vice president of global commercial operations at Amgen will present at both conferences. The webcasts from these events will be broadcast over the internet simultaneously and will be available to members of the news media, investors and the general public.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The webcasts, as with other selected presentations regarding developments in Amgen’s business given by management at certain investor and medical conferences, can be found on Amgen’s website, www.amgen.com, under Investors. Information regarding presentation times, webcast availability and webcast links are noted on Amgen’s Investor Relations Events Calendar. The webcast will be archived and available for replay for at least 90 days after the event.

On August 31, 2023 Alector, Inc. (Nasdaq: ALEC), a clinical-stage biotechnology company pioneering immuno-neurology, reported that management will participate in the following upcoming investor conferences (Press release, Alector, AUG 31, 2023, View Source [SID1234634792]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Morgan Stanley 21st Annual Global Healthcare Conference (New York, New York)
Monday, September 11, 2023 at 4:55 p.m. ET, fireside chat

H.C. Wainwright 25th Annual Global Investment Conference (New York, New York)
Tuesday, September 12, 2023 at 2:30 p.m. ET, corporate presentation

Cantor Global Healthcare Conference (New York, New York)
Thursday, September 28, 2023 at 8:35 a.m. ET, fireside chat

Webcasts will be available on the "Events & Presentations" page within the Investors section of the Alector website at View Source Replays of the webcasts will be available on the Alector website for 90 days following the presentation dates.